Split History
ETFs Holding BSTC »    BSTC Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Biospecifics Technologies is a biopharmaceutical company. Co. has a development and license agreement with Endo Global Ventures for injectable collagenase for marketed indications and indications in development. Injectable collagenase clostridium histolyticum is marketed as XIAFLEX® (or Xiapex® in Europe). The marketed indications involving Co.'s injectable collagenase are Dupuytren's contracture and Peyronie's disease. Other clinical indications for which Co.'s collagenase injection has been tested include keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy. According to our BSTC split history records, Biospecifics Technologies has had 1 split.
BSTC split history picture
Biospecifics Technologies (BSTC) has 1 split in our BSTC split history database. The split for BSTC took place on April 21, 1992. This was a 2 for 1 split, meaning for each share of BSTC owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.

When a company such as Biospecifics Technologies splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the BSTC split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Biospecifics Technologies shares, starting with a $10,000 purchase of BSTC, presented on a split-history-adjusted basis factoring in the complete BSTC split history. BSTC split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/15/2009
End date: 12/13/2019
Start price/share: $29.90
End price/share: $59.66
Dividends collected/share: $0.00
Total return: 99.53%
Average Annual Total Return: 7.15%
Starting investment: $10,000.00
Ending investment: $19,949.03
Years: 10.00
Date Ratio
04/21/19922 for 1
BSTC is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

BSX Split History
BTI Split History
BTX Split History
CAH Split History
CALA Split History
CAPR Split History
CASC Split History
CATB Split History
CBIO Split History
CBLI Split History

Also explore: BSTC shares outstanding history

Protalix BioTherapeutics, Inc. (PLX)
Euroseas Ltd. (ESEA)
QuickLogic Corporation (QUIK)
iMedia Brands, Inc. (IMBI)
Akers Biosciences, Inc. (AKER)
NeuroMetrix, Inc. (NURO)
TRACON Pharmaceuticals (TCON)
SELLAS Life Sciences Group, Inc. (SLS)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Camber Energy, Inc. (CEI)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

BSTC Insider Buying

BSTC Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.